[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 194, "companyOfficers": [{"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1740787200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.08, "open": 2.08, "dayLow": 1.93, "dayHigh": 2.095, "regularMarketPreviousClose": 2.08, "regularMarketOpen": 2.08, "regularMarketDayLow": 1.93, "regularMarketDayHigh": 2.095, "payoutRatio": 0.0, "beta": 0.906, "forwardPE": -1.5348837, "volume": 205490, "regularMarketVolume": 205490, "averageVolume": 481269, "averageVolume10days": 320950, "averageDailyVolume10Day": 320950, "bid": 1.93, "ask": 2.02, "bidSize": 1, "askSize": 1, "marketCap": 112049392, "fiftyTwoWeekLow": 1.815, "fiftyTwoWeekHigh": 9.69, "priceToSalesTrailing12Months": 39.790268, "fiftyDayAverage": 2.4615, "twoHundredDayAverage": 5.057525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -80679560, "profitMargins": 0.0, "floatShares": 37107606, "sharesOutstanding": 52314000, "sharesShort": 2002749, "sharesShortPriorMonth": 1998350, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0354, "heldPercentInsiders": 0.00822, "heldPercentInstitutions": 0.90583, "shortRatio": 8.88, "shortPercentOfFloat": 0.0479, "impliedSharesOutstanding": 5143130, "bookValue": 4.258, "priceToBook": 0.46500707, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -127499000, "trailingEps": -1.14, "forwardEps": -1.29, "enterpriseToRevenue": -28.65, "enterpriseToEbitda": 0.617, "52WeekChange": -0.68292683, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 1.98, "targetHighPrice": 15.0, "targetLowPrice": 3.0, "targetMeanPrice": 10.28571, "targetMedianPrice": 12.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 290110016, "totalCashPerShare": 5.126, "ebitda": -130713000, "totalDebt": 97381000, "quickRatio": 8.068, "currentRatio": 8.141, "totalRevenue": 2816000, "debtToEquity": 40.412, "revenuePerShare": 0.05, "returnOnAssets": -0.26198, "returnOnEquity": -0.65078, "grossProfits": -2030000, "freeCashflow": -68974248, "operatingCashflow": -110822000, "revenueGrowth": -0.908, "grossMargins": -0.72088, "ebitdaMargins": 0.0, "operatingMargins": -55.20602, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "TScan Therapeutics, Inc.", "longName": "TScan Therapeutics, Inc.", "regularMarketChangePercent": -4.8076878, "regularMarketPrice": 1.98, "exchange": "NGM", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1741382400, "regularMarketTime": 1741381201, "messageBoardId": "finmb_583057578", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.98, "postMarketChange": 0.0, "regularMarketChange": -0.099999905, "regularMarketDayRange": "1.93 - 2.095", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 481269, "fiftyTwoWeekLowChange": 0.16499996, "fiftyTwoWeekLowChangePercent": 0.090909064, "fiftyTwoWeekRange": "1.815 - 9.69", "fiftyTwoWeekHighChange": -7.7099996, "fiftyTwoWeekHighChangePercent": -0.7956656, "fiftyTwoWeekChangePercent": -68.29269, "epsTrailingTwelveMonths": -1.14, "epsForward": -1.29, "epsCurrentYear": -1.1295, "priceEpsCurrentYear": -1.752988, "fiftyDayAverageChange": -0.4814999, "fiftyDayAverageChangePercent": -0.1956124, "twoHundredDayAverageChange": -3.0775251, "twoHundredDayAverageChangePercent": -0.6085042, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]